Streetbeat News

Equity Actions

OSIS

Oppenheimer analyst Christopher Glynn maintains an Outperform rating on OSI Systems (NASDAQ:OSIS) and raises the price target from $133 to $157.

Portfolio Pulse from richadhand@benzinga.com

August 25, 2023 | 12:45 pm

MYO

Myomo announced the pricing of a $4.4 million public offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 12:30 pm

GHBWF

GLASF

Cannabis company Glass House Brands Inc. has raised $10.9 million in the first tranche of its $15 million Series D preferred stock offering. The funds will be used to expand cultivation capabilities and retail footprint, with plans to open new dispensaries across California. The company expects to raise an additional $4.1 million in subsequent closings of tranches under the offering.

Portfolio Pulse from Jelena Martinovic

August 25, 2023 | 12:28 pm

BTCUSD

ETHUSD

HIBB

INTU

NVDA

SPY

The Fear & Greed Index has moved to the 'Fear' zone ahead of Powell's speech. Intuit, Hibbett, and three other stocks are to be watched. Ark Invest sold Nvidia shares worth nearly $1.9M. Bitcoin's future is speculated to reach a million dollars. Coinbase delisted six cryptocurrencies. Tech giants Ericsson and Huawei renewed their patent pact in the 5G era. Amazon is in early talks with Disney for ESPN streaming partnership. Tesla's Diner-Supercharger concept in LA gets green signal. Novo Nordisk's Ozempic may be propelled to greater heights by three new markets.

Portfolio Pulse from Akanksha Bakshi

August 25, 2023 | 12:08 pm

IMVT

ROIV

XBI

Vivek Ramaswamy, a Republican presidential candidate and founder of Roivant Sciences, Inc. (NASDAQ:ROIV), has seen his company's stock rise since announcing his candidacy. A $1,000 investment in Roivant when Ramaswamy announced his candidacy would have yielded a 30% return in six months. This compares to a 9.5% gain by the S&P 500 Index and a nearly 6% drop by the SPDR S&P Biotech ETF (NYSE:XBI). Roivant's subsidiaries include publicly listed Immunovant, Inc. (NASDAQ:IMVT).

Portfolio Pulse from Shanthi Rexaline

August 25, 2023 | 12:07 pm

FBRX

Camac Partners and ATG Capital Management, who collectively own about 8.5% stake in Forte Biosciences, have filed a definitive proxy statement in connection with Forte's 2023 annual meeting scheduled for September 19.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 12:04 pm

BJDX

Bluejay Diagnostics has announced a registered direct offering priced at-the-market under Nasdaq rules, amounting to $1.59M.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 12:02 pm

META

Meta Platforms, Inc (NASDAQ:META) has discontinued Messenger Lite, a stripped-back version of its messaging app primarily targeting users with low-end Android devices. The app will become completely inaccessible by September 18. Users are being redirected to the full Messenger or FB Lite. The company also plans to discontinue SMS support from next month. However, Meta is showing interest in enhancing user privacy, with plans to incorporate end-to-end encryption by default in Messenger by the end of 2023.

Portfolio Pulse from Anusuya Lahiri

August 25, 2023 | 11:51 am

BX

Blackstone Group Inc. is selling a 22% stake in Bellagio Las Vegas, according to the Wall Street Journal.

Portfolio Pulse from Charles Gross

August 25, 2023 | 11:32 am

MSFT

The article discusses the hypothetical returns of an investment in Microsoft Corp. (NASDAQ:MSFT) made 28 years ago when Windows 95 was launched. The investment of $1,000 would now be worth $53,596, a 5,224% return. During the same period, the Nasdaq Composite index has delivered a return of 1,714%.

Portfolio Pulse from Rounak Jain

August 25, 2023 | 11:08 am